You did the hard part — the weight came off. But nobody told you what rapid loss without hormonal support costs a menopausal body: muscle, bone, and the metabolic health you started this to protect. And nobody built you an exit. That's the gap Luma exists to close.
Panel first, always — your taper is built on your numbers.
Here's what the GLP-1 boom got right: the medication works. Here's what it skipped: in menopause, up to a third of rapid weight loss can come from lean mass — the muscle and bone density your hormones are already fighting to keep. Lose it, and your metabolism slows, which is the exact setup for regaining the weight the moment the injection stops. [CITATION PENDING — DR. ALIZAIDY]
So the industry's answer became: don't stop. Forever medication, forever subscription. We think that's backwards. The medication was supposed to be a bridge, not a home. Luma builds the other side of the bridge — the hormonal support, the taper, the retest schedule — so what you lost stays lost, and what you kept stays yours.
Your $49 panel plus body-composition check-in. We find out what the medication has actually cost you so far — and what it hasn't.
Before the dose moves, we move: protein, resistance work, and hormonal support where your labs justify it. You taper from strength, not from hope.
Dose steps down on your clinician's schedule, watched against your daily logs. Hunger spikes, energy dips — your physician sees them the same month they happen.
Off the medication, on a plan. Retest at week 6. Adjust. That's not the end of care — it's just care without the injection.